We use essential cookies for the site to work and optional analytics and marketing cookies. You can accept or reject them — your choice can be changed at any time. Learn more
saúde
Wondering if weight loss medications affect your bones? Here's what the research actually shows about GLP-1 drugs, bone density, and who should pay closer attention.
Understanding the legal framework and documented risks of importing GLP-1 weight loss pens from other countries before making a decision.
Wondering if Mounjaro affects your birth control? Here's what the research shows about tirzepatide and oral contraceptive absorption, plus practical guidance.
Brazilian courts have increasingly addressed health plan coverage for obesity medications. Learn what the legal framework looks like and what patients using OzemPro should know before filing a claim.
Brazil's health regulator took action against berberine supplements. Here's what you need to know about the compound, the comparison to Ozempic, and the regulatory reality.
A clear-eyed look at the most common side effects reported with Ozivy GLP-1 treatment, how they typically progress, and when to seek medical guidance.
Rapid weight loss from GLP-1 medications can leave skin looking loose. Here's what research shows about supporting skin health during your transformation.
Discover why Mounjaro costs significantly more in Brazil than in the United States. From import tariffs to regulatory fees, here is what drives the price gap.
Learn which medications may interact with semaglutide and tirzepatide, and how to manage your medication safety when using GLP-1 therapies.
The FDA warning on Ozempic and thyroid cancer might worry you. Here's what science actually shows and who genuinely needs to be concerned.
